Aaron Cowen’s Molecular Partners MOLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.6M Hold
2,221,494
0.16% 57
2026
Q1
$8.82M Hold
2,221,494
0.23% 49
2025
Q4
$9.68M Hold
2,221,494
0.2% 62
2025
Q3
$8.24M Hold
2,221,494
0.21% 63
2025
Q2
$8.49M Hold
2,221,494
0.26% 55
2025
Q1
$8.62M Hold
2,221,494
0.32% 55
2024
Q4
$10.5M Buy
2,221,494
+1,821,494
+455% +$10M 0.36% 55
2024
Q3
$2.03M Hold
400,000
0.07% 75
2024
Q2
$2.89M Hold
400,000
0.11% 64
2024
Q1
$1.68M Hold
400,000
0.06% 78
2023
Q4
$1.67M Hold
400,000
0.08% 69
2023
Q3
$1.66M Hold
400,000
0.09% 68
2023
Q2
$2.49M Hold
400,000
0.13% 70
2023
Q1
$2.42M Hold
400,000
0.1% 67
2022
Q4
$2.62M Hold
400,000
0.11% 62
2022
Q3
$2.68M Hold
400,000
0.11% 63
2022
Q2
$2.71M Hold
400,000
0.1% 76
2022
Q1
$8.22M Hold
400,000
0.25% 56
2021
Q4
$7.67M Hold
400,000
0.15% 65
2021
Q3
$7.84M Hold
400,000
0.13% 72
2021
Q2
$8.2M Buy
+400,000
New +$7.94M 0.12% 83

Other funds holding MOLN

Aaron Cowen's MOLN Position: Q2 2026 in Review

Aaron Cowen held its Molecular Partners (MOLN) position steady in Q2 2026 at 2,221,494 shares worth $8.6M. The position accounts for 0.16% of the portfolio, ranked #57.

Aaron Cowen first reported a position in MOLN in Q2 2021 and has held it in 21 quarters since. The position peaked at $10.5M in Q4 2024. 5 funds tracked by Wall St. Rank hold MOLN as of Q2 2026.

  • Aaron Cowen held 2,221,494 shares of Molecular Partners worth $8.6M as of Q2 2026.
  • Aaron Cowen left its Molecular Partners share count unchanged in Q2 2026.
  • Molecular Partners made up 0.16% of Aaron Cowen's portfolio in Q2 2026, its #57 holding.
  • Aaron Cowen first reported a position in Molecular Partners in Q2 2021 and has held it in 21 quarters since.
  • Aaron Cowen's Molecular Partners position peaked at $10.5M in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Molecular Partners as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.